About Faraday Pharmaceuticals
Faraday Pharmaceuticals is a biopharmaceutical company pursuing the development of elemental reducing agents (ERAs). This pioneering approach focuses on the ability of specific reduced forms of elements to improve outcomes for patients.
Faraday Pharmaceuticals was founded in 2014 to advance the pioneering research of Mark Roth generated from his lab at the Fred Hutchinson Cancer Research Center. Faraday is headquartered in South Lake Union, Seattle.